Shultz, MA
Joseph Carl Shultz, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20120158826 | SYSTEM AND METHOD FOR PROVIDING AN OPTIMAL MOTIVATIONAL RESPONSE - A system for providing an optimal motivational response is provided. The system includes an input device configured to receive at least one client input from the client. The system further includes a processor configured to analyze the at least one client input received from the client and generate a current state of the client based on the at least one client input. The processor is further configured to analyze the current state of the client and determine an optimal motivational technique for the client based on the current state of the client and the at least one client input. The processor is also configured to generate an optimal motivational response based on the optimal motivational technique. The system further includes an output device configured to display the optimal motivational response to the client. | 06-21-2012 |
Mary Jane Shultz, Natick, MA US
Michael Shultz, Stow, MA US
Patent application number | Description | Published |
---|---|---|
20090247547 | HYDROXAMATE-BASED INHIBITORS OF DEACETYLASES B - The present teachings relate to compounds of Formula I: | 10-01-2009 |
20110053925 | Hydroxamate-Based Inhibitors of Deacetylases - The present teachings relate to compounds of Formula I: | 03-03-2011 |
20110060009 | Hydroxamate-Based Inhibitors of Deacetylases - The present teachings relate to compounds of Formula I: | 03-10-2011 |
Michael Shultz, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20100008923 | Organic Compounds - The invention relates to pharmaceutical compositions containing inhibitors of histone deacetylase and B vitamins and methods of use thereof, in the treatment of HDAC dependent diseases and for the manufacture of pharmaceutical preparations for the treatment of said diseases. | 01-14-2010 |
20100022514 | Heterocycle Compounds and Methods of Use Thereof - The invention relates to the use of compounds in the treatment of deacetylase-associated diseases and for the manufacture of pharmaceutical preparations for the treatment of said diseases. | 01-28-2010 |
20110014186 | ARYLSULFONAMIDE-BASED MATRIX METALLOPROTEASE INHIBITORS - The present invention provides a compound of formula (I): | 01-20-2011 |
20110112076 | SELECTIVE HYDROXAMIC ACID BASED MMP-12 AND MMP-13 INHIBITORS - The present invention provides a compound of formula (I) said compound is inhibitor of MMP-12 and/or MMP-13, and thus can be employed for the treatment of a disorder or disease characterized by abnormal activity of MMP-12 and/or MMP-13. Accordingly, the compound of formula (I) can be used in treatment of disorders or diseases mediated by MMP-12 and/or MMP-13. Finally, the present invention also provides pharmaceutical composition that include the compound of formula (I). | 05-12-2011 |
20110183964 | HYDROXAMATE-BASED INHIBITORS OF DEACETYLASES B - The present teachings relate to compounds of Formula I: | 07-28-2011 |
20140031399 | SELECTIVE HYDROXAMIC ACID BASED MMP-12 AND MMP-13 INHIBITORS - The present invention provides a compound of formula (I): | 01-30-2014 |
Michael Shultz, Lexington, MA US
Patent application number | Description | Published |
---|---|---|
20120258954 | ArylSulfonamide Based Matrix Metalloprotease Inhibitors - The present invention provides a compound of formula (I): | 10-11-2012 |
Michael David Shultz, Cambrdige, MA US
Patent application number | Description | Published |
---|---|---|
20150126513 | 4-PIPERIDINYL COMPOUNDS FOR USE AS TANKYRASE INHIBITORS - The present invention provides for compounds of formula (I): | 05-07-2015 |
Michael David Shultz, Lexington, MA US
Patent application number | Description | Published |
---|---|---|
20130096105 | ArylSulfonamide Based Matrix Metalloprotease Inhibitors - The present invention provides a compound of formula (I): | 04-18-2013 |
20140235620 | 3-PYRIMIDIN-4-YL-OXAZOLIDIN-2-ONES AS INHIBITORS OF MUTANT IDH - The invention is directed to a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein R | 08-21-2014 |
20140275083 | 3-PYRIMIDIN-4-YL-OXAZOLIDIN-2-ONES AS INHIBITORS OF MUTANT IDH - The invention is directed to a formula (I): | 09-18-2014 |
20150045398 | ArylSulfonamide-Based Matrix Metalloprotease Inhibitors - The present invention provides a compound of formula (I): | 02-12-2015 |
Michael David Shultz, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20150025070 | NOVEL 2-PIPERIDIN-1-YL-ACETAMIDE COMPOUNDS FOR USE AS TANKYRASE INHIBITORS - The present invention provides for compounds of formula (I): | 01-22-2015 |
Micheal Shultz, Stow, MA US
Patent application number | Description | Published |
---|---|---|
20080255149 | Carboxyamine Compounds and Methods of Use Thereof - The invention relates to the use of carboxyamine compounds and salts thereof in the treatment of HDAC dependent diseases and for the manufacture of pharmaceutical preparations for the treatment of said diseases. | 10-16-2008 |
Traci Anne Shultz, Medway, MA US
Patent application number | Description | Published |
---|---|---|
20140150518 | METHOD AND APPARATUS FOR CALIBRATING A DISPENSER - A method of calibrating a dispenser of the type having a material dispensing unit that is configured to dispense material on a substrate includes providing a weigh scale having a plate configured to receive material dispensed on the plate, dispensing one or more patterns of material on the plate; weighing the amount of material dispensed on the plate, and comparing the weighed amount of material to a designated amount of material. The act of dispensing one or more patterns of material replicates at least a portion of patterns of material dispensed on the substrate during a dispensing operation. A controller for performing the method is further disclosed. | 06-05-2014 |